Insider · CIK 0001703623

Carroll David Francis

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001703623

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−28.8K sh	—	—	0
2023-07-11	IVERIC bio, Inc.D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−44.2K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−75K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−70K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−115K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−75K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−150K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−38K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−55K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	SVP, Chief Financial Officer	DDisposition to Issuer	−26.3K sh	—	—	0
2023-06-26	IVERIC bio, Inc.G Gift	SVP, Chief Financial Officer	GGift	−24.3K sh	—	—	44,152
2023-05-01	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+63.5K sh	$2.81	+$178K	131,972
2023-05-01	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−63.5K sh	$37.04	−$2.35M	68,472
2023-05-01	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−63.5K sh	$2.81	−$178K	0
2023-04-24	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−48.2K sh	$1.45	−$69.8K	0
2023-04-24	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−48.2K sh	$30.21	−$1.46M	68,472
2023-04-24	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+48.2K sh	$1.45	+$69.8K	116,643
2023-04-21	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−1,829 sh	$1.45	−$2,652.05	48,171
2023-04-21	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−1,829 sh	$30.00	−$54.9K	68,472
2023-04-21	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+1,829 sh	$1.45	+$2,652.05	70,301
2023-01-03	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−3,602 sh	$20.06	−$72.3K	68,472
2023-01-02	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−8,750 sh	—	—	26,250
2023-01-02	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+8,750 sh	—	—	72,074
2022-12-20	IVERIC bio, Inc.Stock Option (right to buy)A Award	SVP, Chief Financial Officer	AAward	+75K sh	—	—	75,000
2022-12-20	IVERIC bio, Inc.Restricted Stock UnitsA Award	SVP, Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2022-12-19	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−5,671 sh	$21.51	−$122K	63,324
2022-12-18	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+14.4K sh	—	—	68,995
2022-12-18	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−14.4K sh	—	—	28,750
2022-12-13	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−4,932 sh	$21.73	−$107K	54,620
2022-12-12	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−2,405 sh	$20.66	−$49.7K	48,593
2022-12-12	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	0
2022-12-12	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+12.5K sh	—	—	59,552
2022-12-12	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−1,541 sh	$21.25	−$32.7K	47,052
2022-12-09	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+10K sh	—	—	50,998
2022-12-09	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	10,000
2022-04-05	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−4,684 sh	$19.01	−$89K	40,166
2022-04-05	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+4,684 sh	$1.45	+$6,791.8	44,850
2022-04-05	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−4,684 sh	—	—	50,000
2022-04-04	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−600 sh	$19.01	−$11.4K	40,166
2022-04-04	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−40.3K sh	$18.49	−$746K	40,766
2022-04-04	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+20.3K sh	$1.45	+$29.5K	81,107
2022-04-04	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−20.3K sh	—	—	54,684
2022-04-01	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−2,144 sh	$17.00	−$36.4K	60,791
2022-03-25	IVERIC bio, Inc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+16.8K sh	$1.45	+$24.3K	79,707
2022-03-25	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−16.8K sh	—	—	75,000
2022-03-25	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−16.8K sh	$17.02	−$285K	62,935
2022-03-18	IVERIC bio, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−8,237 sh	—	—	91,763
2022-03-18	IVERIC bio, Inc.S Sale	SVP, Chief Financial Officer	SSale	−11.6K sh	$17.00	−$197K	62,944

Recent filings

Accepted (ET)
Jul 134
Carroll David Francis0001104659-23-080691
SEC(opens sec.gov)
Jun 284
Carroll David Francis0001410939-23-000101
SEC(opens sec.gov)
May 34
Carroll David Francis0001410939-23-000060
SEC(opens sec.gov)
Apr 254
Carroll David Francis0001410939-23-000057
SEC(opens sec.gov)

Companies

IVERIC bio, Inc.SVP, Chief Financial Officer

Address

C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 35TH FLOOR

NEW YORK, NY, 10119